Replies to post #91342 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Yes, I read that report.

Presently, I don’t see much connection to or application of Anavex molecules, which we’d hope could suppress enervation of cancer masses. No evidence, just yet, for that.

Nonetheless, the multitude of efficacies and applications for the many drug candidates in the Anavex pipeline are enormous.

Understandably, and appropriately, we presently focus on Anavex2-73 in the suppression or reversal of Alzheimer’s symptoms. But therapy for Rett Syndrome is closely approaching; and I’m certain others will follow.

I’ve contended this before — Anavex therapeutic technologies will transform 21st-century medical care even more than antibiotics did in the last century. Aging and geriatric diseases may be well-controlled by our emerging company. Cancers are not out of the question.